GLGuqing Luo

Guqing Luo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Guqing Luo has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Song Ding

    Department of Cardiology, and Center Laboratory of Punan Branch, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China

    2 shared publications
  • Wenyi Xu

    Department of Cardiology The Second Affiliated Hospital School of Medicine State Key Laboratory of Transvascular Implantation Devices Heart Regeneration and Repair Key Laboratory of Zhejiang province Zhejiang University Hangzhou People's Republic of China

    2 shared publications
  • Yuxuan Qian

    National Center for Orthopaedics Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai People's Republic of China

    2 shared publications
  • Zhinan Wu

    State Key Laboratory for Innovation and Transformation of Luobing Theory; Key Laboratory of Cardiovascular Remodeling and Function Research of MOE, NHC, CAMS and Shandong Province; Department of Cardiology, Qilu Hospital of Shandong University, Jinan 250012, China

    2 shared publications
  • Fei Liao

    Department of Cardiology The Second Affiliated Hospital School of Medicine State Key Laboratory of Transvascular Implantation Devices Heart Regeneration and Repair Key Laboratory of Zhejiang province Zhejiang University Hangzhou People's Republic of China

    1 shared publication
  • Fei Liao

    Department of Cardiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

    1 shared publication

Latest Publications

  • Open Access

    NCOA4 Accelerates Abdominal Aortic Aneurysm Formation by Regulating Macrophage Activation and Ferroptosis via STAT1–CH25H Axis

    by Zhinan Wu, Yuxuan Qian, Wenyi Xu, Fei Liao, Xueliang Liu, Xiao Kuang, Guqing Luo, Xinjie He, Lixian Jiang, Song Ding

    Abdominal aortic aneurysm (AAA) is a life‐threatening condition lacking effective pharmacological treatments, with emerging evidence highlighting the fundamental role of ferroptosis in its progression. Nuclear receptor coactivator 4 (NCOA4), known to mediate ferritinophagy and contribute to ferroptosis, is upregulated in macrophages from both angiotensin II (Ang II)‐induced murine AAA models and human AAA tissues. Global deletion of Ncoa4 in mice suppressed Ang II‐induced AAA formation. Combined approaches using bone marrow transplantation and macrophage‐specific adeno‐associated virus (AAV) confirmed that Ncoa4 knockdown in macrophages alleviates extracellular matrix (ECM) degeneration, inflammation, and vascular damage. Mechanistically, NCOA4 interacts with signal transducer and activator of transcription 1 (STAT1) to co‐activate the transcription of cholesterol 25‐hydroxylase (CH25H), an enzyme that catalyzes the production of 25‐hydroxycholesterol (25‐HC). Elevated 25‐HC levels were detected in the serum of both Ang II‐induced AAA mice and human AAA patients, and they promoted macrophage activation and ferroptosis, thereby driving AAA progression. Importantly, knockdown of Ch25h using lipid nanoparticle‐loaded microbubbles (LNP/MBs) attenuated macrophage ferroptosis and AAA progression. These findings reveal a critical role of the NCOA4/STAT1/CH25H axis in AAA pathogenesis and offer promising biomarkers and therapeutic strategies for the disease.

  • Open Access

    NR1D1 Deletion Induces Rupture‐Prone Vulnerable Plaques by Regulating Macrophage Pyroptosis via the NF‐κB/NLRP3 Inflammasome Pathway

    by Zhinan Wu, Fei Liao, Guqing Luo, Yuxuan Qian, Xinjie He, Wenyi Xu, Song Ding, Jun Pu

    Vulnerable plaque rupture is the main trigger of most acute cardiovascular events. But the underlying mechanisms responsible for the transition from stable to vulnerable plaque remain largely unknown. Nuclear receptor subfamily 1 group D member 1 (NR1D1), also known as REV‐ERB α, is a nuclear receptor that has shown the protective role in cardiovascular system. However, the effect of NR1D1 on vulnerable plaque rupture and its underlying mechanisms are still unclear. By generating the rupture‐prone vulnerable plaque model in hypercholesterolemic ApoE−/− mice and NR1D1−/−ApoE−/− mice, we demonstrated that NR1D1 deficiency significantly augmented plaque vulnerability/rupture, with higher incidence of intraplaque hemorrhage (78.26% vs. 47.82%, P = 0.0325) and spontaneous plaque rupture with intraluminal thrombus formation (65.21% vs. 39.13%, P = 0.1392). In vivo experiments indicated that NR1D1 exerted a protective role in the vasculature. Mechanically, NR1D1 deficiency aggravates macrophage infiltration, inflammation, and oxidative stress. Compared with the ApoE−/− mice, NR1D1−/−ApoE−/− mice exhibited a significantly higher expression level of pyroptosis‐related genes in macrophages within the plaque. Further investigation based on mice bone marrow‐derived macrophages (BMDMs) confirmed that NR1D1 exerted a protective effect by inhibiting macrophage pyroptosis in a NLRP3‐inflammasome‐dependent manner. Besides, pharmacological activation of NR1D1 by SR9009, a specific NR1D1 agonist, prevented plaque vulnerability/rupture. In general, our findings provide further evidences that NR1D1 plays a protective role in the vasculature, regulates inflammation and oxidative stress, and stabilizes rupture‐prone vulnerable plaques.